Investec Asset Management LTD reduced its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 0.5% during the 3rd quarter, Holdings Channel reports. The firm owned 2,173,066 shares of the healthcare conglomerate’s stock after selling 10,013 shares during the quarter. UnitedHealth Group comprises about 1.9% of Investec Asset Management LTD’s holdings, making the stock its 9th largest position. Investec Asset Management LTD’s holdings in UnitedHealth Group were worth $425,595,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Blue Chip Partners Inc. bought a new position in UnitedHealth Group in the second quarter valued at approximately $110,000. Bruderman Asset Management LLC bought a new position in UnitedHealth Group in the second quarter valued at approximately $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its stake in UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after acquiring an additional 520 shares during the last quarter. BDO Wealth Advisors LLC bought a new position in UnitedHealth Group in the second quarter valued at approximately $121,000. Finally, Acrospire Investment Management LLC boosted its stake in UnitedHealth Group by 130.7% in the second quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after acquiring an additional 400 shares during the last quarter. 86.11% of the stock is currently owned by institutional investors and hedge funds.

Shares of UnitedHealth Group Inc (NYSE UNH) opened at $248.47 on Monday. UnitedHealth Group Inc has a twelve month low of $156.49 and a twelve month high of $248.74. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.58. The company has a market cap of $240,240.00, a price-to-earnings ratio of 23.20, a P/E/G ratio of 1.43 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping analysts’ consensus estimates of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The business had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.57 billion. During the same period last year, the business posted $2.11 earnings per share. The firm’s quarterly revenue was up 9.5% on a year-over-year basis. analysts predict that UnitedHealth Group Inc will post 12.51 EPS for the current year.

In related news, Director Kenneth Irwin Shine sold 198 shares of the firm’s stock in a transaction on Friday, January 19th. The shares were sold at an average price of $242.55, for a total transaction of $48,024.90. Following the sale, the director now directly owns 1,790,567 shares in the company, valued at $434,302,025.85. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director William C. Ballard, Jr. sold 10,000 shares of the firm’s stock in a transaction on Tuesday, January 23rd. The stock was sold at an average price of $246.38, for a total transaction of $2,463,800.00. Following the sale, the director now owns 76,637 shares in the company, valued at $18,881,824.06. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 43,853 shares of company stock worth $9,980,908. 0.89% of the stock is currently owned by company insiders.

A number of brokerages have issued reports on UNH. Deutsche Bank raised their price objective on shares of UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research note on Wednesday, January 17th. Wells Fargo & Co reaffirmed an “outperform” rating and issued a $245.00 price objective (up from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Leerink Swann reaffirmed an “outperform” rating on shares of UnitedHealth Group in a research note on Friday, December 1st. Citigroup raised their price objective on shares of UnitedHealth Group from $213.00 to $235.00 and gave the company a “buy” rating in a research note on Wednesday, October 18th. Finally, BMO Capital Markets assumed coverage on shares of UnitedHealth Group in a research report on Monday, October 16th. They set an “outperform” rating and a $250.00 price target on the stock. Two investment analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $243.22.

COPYRIGHT VIOLATION NOTICE: “Investec Asset Management LTD Sells 10,013 Shares of UnitedHealth Group Inc (UNH)” was reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this story on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The legal version of this story can be accessed at https://theolympiareport.com/2018/01/29/investec-asset-management-ltd-sells-10013-shares-of-unitedhealth-group-inc-unh.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.